Talking therapy tested for picky eating disorder in teens and young adults
NCT ID NCT06463470
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This trial tests whether a type of talking therapy called CBT-AR can help young people aged 12 to 25 with avoidant/restrictive food intake disorder (ARFID). ARFID is an eating disorder where people avoid certain foods or eat very little, not because of body image concerns but due to fear, lack of interest, or sensory sensitivity. The study looks at whether the therapy is practical, acceptable to patients and families, and effective at reducing symptoms. It involves weekly sessions and tracks changes in eating habits, weight, and emotional well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cognitive behavioural therapy (CBT-AR)
- What this could lead to
- If it works, this could offer a structured therapy option for young people with ARFID, helping them eat more comfortably and reduce food-related anxiety.
- What could go wrong
- This is a very small early feasibility study with only 3 participants, so results may not apply widely. The therapy may not work for everyone and could cause temporary anxiety around eating.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Current primary diagnosis of ARFID according to DSM-5 criteria as determined by the treating team (the eating disorders Orygen Specialist Program * Presenting for treatment in the eating disorders Orygen Specialist Program * If \<16yo, or \>16 but underweight (BMI \<18.5) and living with their parents/guardian, a parent/guardian should be involved in the treatment. Exclusion Criteria: * Current tube feeding * Inappropriateness for CBT-AR as determined by the clinicians (e.g. if there are more urgent issues to first manage such as high suicidal ideation, if participants do not have adequate comprehension capability, etc)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Avoidant/restrictive food intake disorder (arfid) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Orygen Youth Health - Parkville - Parkville
Melbourne, Victoria, 3052, Australia
-
Orygen Youth Health - Sunshine - Sunshine
Melbourne, Victoria, 3020, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.